Pharmacodynamic evaluation of proniosomal transdermal therapeutic gel containing celecoxib

ScienceAsia

Volumn 36, Issue 4, 2010, Pages 305-311

  Alam, M Intakhab ^a   Baboota, Sanjula ^a   Kohli, Ranchan ^a   Ali, Javed ^a   Ahuja, Alka ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

NSAID; Osteoarthritis; Proniosomes; TDDS

Indexed keywords

EID: 79251518257     PISSN: 15131874     EISSN: None     Source Type: Journal    
DOI: 10.2306/scienceasial513-1874.2010.36.305     Document Type: Article

References (19)

1. Huang BY, Jung BH, Chung SJ, Lee MH, Shim CK (1997) In vitro skin permeation of nicotine from proliposomes. J Contr Release 49, 177-84.
2. Fang JY, Yu SY, Wu PC, Huang YB (2001) In vitro skin permeation of estradiol from various proniosome formulations. Int J Pharm 215, 91-9.
3. Varshosaz J, Pardakhty A, Baharanchi SMH (2005) Sorbitan monopalmitate-based proniosome for transdermal delivery of Chlorpheniramine maléate. Drug Deliv 12, 75-82.
4. Hofland H, Geest RV, Bodde H, Junginger H, Boustra J (1994) Estradiol permeation from nonionic surfactant vesicles through human stratum corneum in vitro. Pharmaceut Res 11, 659-64.
5. Kean WF, Watson B (2005) The use of NSAIDs in rhumatic disorders 2005: a global perspective. Inflammopharmacology 13, 343-70.
6. Hawkey CJ (1990) Non-steroidal anti-inflammatory drugs and peptic ulcers. BMJ 300, 278-84.
7. Griffin MR, Scheiman JM (2001) Prospects for changing the burden of nonsteroidal anti-inflammatory drug toxicity. Am J Med 110, S33-4.
8. Diwan PV, Reddy MN, Rehana T, Ramakrishna S, Chowdary KPR (2004) β-Cyclodextrin complexes of CXB: molecular-modeling, characterization, and dissolution studies. AAPS PharmSci 6, Article 7.
9. Paulson SK, Vaughn MB, Jessen SM, Lawal Y, Gresk CJ, Yan B, Maziasz TJ, Cook CS, Karim A (2001) Pharmacokinetics of celecoxib after oral administration in dogs and humans: effect of food and site of absorption. J Pharmacol Exp Therapeut 297, 638-45. (Pubitemid 32377995)
10. Plessis J, Ramachandran C, Weiner N, Miller DG (1991) The influence of particle size of liposomes on deposition of drug into skin. Int J Pharm 103, 277-82.
11. Winter CA (1965) Anti-inflammatory testing methods: comparative evaluation of indomethacin and other agents. In: Garattini S, Dukes MNG (eds) Nonsteroidal Anti-Inflammatory Drugs Int. Congr. Ser. No. 82, pp 190-202.
12. Yoshioka T, Sternberg B, Florence AT (1994) Preparation and properties of vesicles (niosomes) of sorbitan monoesters (Span 20, 40, 60, and 80) and a sorbitan triesters (Span 85). Int J Pharm 105, 1-6.
13. Vora B, Khopade AJ, Jain NK (1998) Proniosome based transdermal delivery of levonorgestrel for effective contraception. J Contr Release 54, 149-65. (Pubitemid 28342694)
14. Perrett S, Golding M, Williams WP (1991) A simple method for the preparation of liposomes for pharmaceutical application and characterization of liposomes. J Pharm Pharmacol 43, 154-61.
15. Ishii F, Takemura A, Ishigami Y (1995) Procedure for preparation of lipid vesicles (Liposomes) using coacervation (phase separation) technique. Langmuir 11, 483-6.
16. Krishnaiah YSR, Al-Saidan SM, Chandrasekhar DV, Satyanarayana V (2005) Bioavailability of nerodilolbased transdermal therapeutic system of nicorandil in human volunteers. J Contr Release 106, 111-22.
17. Alsarra IA, Bosela AA, Ahmed SM, Mahrous GM (2005) Proniosomes as a drug carrier for transdermal delivery of Ketorolac. Eur J Pharm Biopharm 59, 485-40).
18. Jia-You F, Song-Tib Y, Pao-Chu W, Yaw-Bin H, YiHung T (2001) In vitro skin permeation of estradiol from various proniosome formulations. Int J Pharm 215, 91-9.
19. Vanhal D, Vanrensen A, Devringer T, Junginger H, Boustra J (1996) Diffusion of estradiol from nonionic surfactant vesicles through human stratum-corneum in vitro. STP Pharma Sci 6, 72-8.